Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Visual impairment in stroke: intervention or not (VISION)
ISRCTN ISRCTN05956042
ClinicalTrials.gov identifier
Public title Visual impairment in stroke: intervention or not (VISION)
Scientific title Visual Impairment in Stroke: Intervention Or Not (VISION) - a randomised controlled trial to investigate whether prism glasses or visual search training are more effective than information only (standard care) in patients with a homonymous hemianopia follow stroke
Acronym VISION
Serial number at source 10134
Study hypothesis The aim of this trial is to be the first step in determining the effectiveness of Fresnel Prisms and Visual Search Strategies compared to standard care in patients with homonymous hemianopia (HH) following a stroke. The trial will be a multicentre three arm individually randomised controlled trial with independent assessment at 6, 12 and 26 weeks post randomisation. Recruitment will occur in hospital and outpatient settings in Bath, Nottingham, Oxford, Salford and Sheffield. 105 patients with HH and without ocular motility impairment, visual inattention or pre-existent visual field impairment will be randomised to 3 groups using an online randomisation system. Allocation will be revealed to the treating clinician, patient and trial coordinator, maintaining blinding for the assessors. The primary outcome will be visual field assessment. Secondary measures will include the Rivermead Mobility Index, VFQ25/10, Nottingham EADL, EQ5D and SF12 questionnaires. Analysis will be by intention to treat. This study has been developed and supported by the UKSRN CSG working with service users. The findings will support a future HTA application.

Website: www.strokevision.org.uk (under construction)
Lay summary
Ethics approval 10/H1003/119
Study design Randomised, interventional screening trial
Countries of recruitment United Kingdom
Disease/condition/study domain Stroke Research Network; Rehabilitation
Participants - inclusion criteria 1. 18 years of age and older
2. Best corrected visual acuity of 6/18 in either eye
3. Homonymous hemianopia
4. Refractive error within ±5Dioptres
5. Vision measures will be established by orthoptic assessment
6. Male or female
Participants - exclusion criteria 1. Inability to consent due to severe cognitive impairment
2. Unwilling to participate in the study
3. Ocularmotility impairment and visual inattention in addition to the visual field impairment (as assessed by the orthoptist)
4. Preexisting visual field impairment
Anticipated start date 01/03/2011
Anticipated end date 31/08/2013
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants Planned Sample Size: 105; UK Sample Size: 105
Interventions 1. After assessment of eligibility patients will be randomised to either treatment with Fresnel prisms, visual search strategies or control group (information only)
2. Prisms will be worn for a minimum of 2 hours per day and visual search strategies will be done for a minimum of 30 minutes per day, both for a minimum of 6 weeks
3. Patients will then be followed up at 6, 12 and 26 weeks post treatment start
4. At baseline and follow up visits participants will have their visual fields will be assessed (primary endpoint) and complete a participant completed outcome measures questionnaire pack along with a reading accuracy test (secondary endpoints)
5. Total duration of participant involvement: 26 weeks
Primary outcome measure(s) Visual field
Secondary outcome measure(s) 1. Visual function questionnaire (VFQ 25-10) – change in perceived ability relating to activities of daily living
2. Rivermead mobility index – change in functional mobility
3. Nottingham extended activities of daily living (NEADL) – change in extended daily living index
4. EQ-5D – change in health related quality of life
5. SF-12 – change of general health status
6. Assessment of reading speed and accuracy (Radner Test)
Sources of funding The Stroke Association (UK)
Trial website
Publications
Contact name Dr  Fiona  Rowe
  Address Thompson Yates Building
Quadrangle Brownlow Hill
  City/town Liverpool
  Zip/Postcode L69 3GB
  Country United Kingdom
Sponsor University of Liverpool (UK)
  Address c/o Ms Lindsay Carter
Department of Clinical Psychology
Thompson Yates Building
Quadrangle Brownlow Hill
  City/town Liverpool
  Zip/Postcode L69 3GB
  Country United Kingdom
Date applied 08/04/2011
Last edited 17/05/2011
Date ISRCTN assigned 08/04/2011
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central